Identification of a nitric oxide-regulated transitional state of Müller glia reveals a key mechanism enabling neuronal regeneration in the injured vertebrate retina.

AbbVie (NYSE: ABBV) today announced topline results from the Phase 3 EPCORE® DLBCL-1 trial evaluating epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, compared to ...

Cells have a remarkable housekeeping system: proteins that are no longer needed, defective, or potentially harmful are labeled with a molecular “tag” and dismantled in the cellular recycling machinery ...

There is an urgent clinical need for rapid, objective, and label-free methods to analyze red blood cell deformations at the single-cell level. A research team led by Prof. Nan Zeng at Tsinghua ...

Bristol Myers Squibb BMY recently obtained FDA approval for the label expansion of Breyanzi (lisocabtagene maraleucel) for the treatment of adult patients with relapsed or refractory (R/R) marginal ...

MUMBAI, India and PRINCETON, N.J., Nov. 25, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE ...

Private-label brands are entering a “super cycle” phase, evolving beyond entry-level price options to become a sophisticated tool for value creation for brand strategy and equity, according to Rachel ...

Blue Label has achieved majority ownership of Cell C. Blue Label has finally achieved its almost decade-long goal of securing a majority stake in Cell C, South Africa’s fourth biggest mobile operator, ...

JOHANNESBURG, Sept 1 (Reuters) - South Africa's Blue Label (BLUJ.J), opens new tab said on Monday that it plans a group restructuring to facilitate the unbundling and potential listing of mobile ...

Blue Label Telecoms currently owns 49.5% of Cell C and is seeking final regulatory approval to buy an additional 4.04% stake. (Photograph by Lesley Moyo) Blue Label Telecoms has started making plans ...